Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder

Neurosci Lett. 2010 Jan 14;468(3):300-2. doi: 10.1016/j.neulet.2009.11.019. Epub 2009 Nov 13.

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP, ADCYAP1: adenylate cyclase-activating polypeptide 1) is a neuropeptide with neurotransmission modulating activity. The associations of the PACAP gene with schizophrenia and hippocampal volume have been reported. We recently reported depression-like behavior in the forced swimming test in PACAP deficient mice. Here we examined a possible association between the PACAP gene and major depressive disorder (MDD) in 637 patients and 967 controls and found that a genetic variant in the gene was associated with MDD. The present results suggest that PACAP signaling might contribute to the pathogenesis of MDD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Depressive Disorder, Major / genetics*
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Pituitary Adenylate Cyclase-Activating Polypeptide / genetics*
  • Polymorphism, Single Nucleotide

Substances

  • ADCYAP1 protein, human
  • Pituitary Adenylate Cyclase-Activating Polypeptide